REG - Assura plc - Notice of Dividend

AssuraAnnouncement

19/05/2025 09:45

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250519:nRSS2075Ja&default-theme=true

RNS Number : 2075J  Assura PLC  19 May 2025

 

19 May 2025

Assura plc

 

Notice of Dividend

 

Assura plc ("Assura" or the "Company"), UK's leading diversified healthcare
REIT, today announces that the next quarterly interim dividend of 0.84 pence
per share will be paid on 9 July 2025 to shareholders on the register on 6
June 2025 (the "Record Date"). The Ex-dividend Date will be 5 June 2025.

 

This interim dividend will be wholly Property Income Distribution ("PID").
Forms to register for gross PIDs are available on the Company's website and
must be returned to the Company registrars, MUFG Corporate Markets at Central
Square, 29 Wellington Street, Leeds, LS1 4DL to arrive by 4.30pm on 26 June
2025. Please refer to Company's website HERE
(https://www.assuraplc.com/investor-relations/shareholder-information/reit-dividends-and-uk-tax)
for more information.

 

Please note that there is no Scrip Dividend Alternative available for this
quarterly dividend and will be paid in full as cash.

 

For future dividend payments, including this one, CREST holders will
automatically receive their dividend via CREST unless they have specifically
opted out.

 

Key dates:

 

Ex-dividend date: 5 June 2025

Record date: 6 June 2025

Dividend payment date: 9 July 2025

 

A separate announcement with additional information concerning shares held on
the Johannesburg Stock Exchange has been published via the SENS system.

 

- Ends -

 

For more information, please contact:

 

 Assura plc                                   Tel: 0161 515 2043
 David Purcell, Investor Relations Director   Email: Investor@assura.co.uk

 FGS Global                                   Tel: 0207 251 3801

                                            Email: Assura-LON@fgsglobal.com
 Gordon Simpson

Grace Whelan

 

Notes to Editors

Assura plc is the UK's leading diversified healthcare REIT. Assura enables
better health outcomes through its portfolio of more than 600 healthcare
buildings, from which over six million patients are served.

 

A UK REIT based in Altrincham, Assura is a constituent of the FTSE 250 and the
EPRA* indices and has a secondary listing on the Johannesburg Stock Exchange.

 

At Assura we BUILD for health and as the first FTSE 250 certified B Corp we
are committed to keeping ESG at the heart of our strategy, creating Healthy
Environments (E) and Healthy Communities (S) and maintaining a Healthy
Business (G).

 

Further information is available at www.assuraplc.com
(http://www.assuraplc.com)

*EPRA is a registered trademark of the European Public Real Estate Association

 

Rule 26.1 information

In accordance with Rule 26.1 of the Takeover Code, a copy of this Announcement
will be made available free of charge, subject to certain restrictions
relating to persons resident in restricted jurisdictions, on Assura's website
at www.assuraplc.com/investor-relations/
(http://www.assuraplc.com/investor-relations/shareholder-information/offer-from-kkr-and-stonepeak)
 no later than 12 noon (London time) on the business day following the date
of this Announcement. For the avoidance of doubt, the contents of the website
referred to in this Announcement are not incorporated into, and do not form
part of, this Announcement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DIVGPUMPAUPAURB